Latest news

Hide mandatory notifications of trade

Minutes EGM 7 October 2013

(7 October 2013) Bionor Pharma ASA (OSE:BIONOR): The Extraordinary General Meeting of Bionor Pharma ASA approved the proposed Repair Offering of issuance of up to 7,500,000 new shares and the authorization to increase the share capital through private placement.

The Repair Offering shall be made through a prospectus approved by the Norwegian Financial Supervisory Authority. Detailed information of the Repair Offering will be published upon approval of prospectus.

Link to the complete minutes of the Extraordinary General Meeting.

Bionor Pharma ASA

Synne H Røine, CFO
Tel + 47 99 22 98 92